Prevalence of positive tuberculin skin tests in foreign-born children

Kristine Fortin1, Ana Carceller, Monique Robert

  • 1Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montréal, Canada.

Insights

Latent tuberculosis is common in foreign-born children, with higher rates in immigrants due to older arrival ages. Tuberculin skin tests (TST) revealed significant prevalence in this population.

Area of Science:

  • Pediatric infectious diseases
  • Global health epidemiology
  • Immigration health

Background:

  • Internationally adopted and immigrant children represent diverse populations with unique health considerations.
  • Tuberculosis (TB) remains a significant global health concern, particularly in endemic regions from which these children often originate.
  • Screening for latent tuberculosis infection is crucial in high-risk pediatric groups.

Purpose of the Study:

  • To determine the prevalence of positive tuberculin skin tests (TST) among internationally adopted and immigrant children.
  • To identify specific risk factors associated with positive TST results in these pediatric populations.

Main Methods:

  • Retrospective medical record review of children seen at a specialized pediatric clinic from 1998-2001.
  • Inclusion criteria: children evaluated at the International Adoption and Immigrant Health Clinic.
  • Data analyzed included demographics, BCG vaccination status, TST results (induration ≥ 10 mm), and chest X-ray findings.

Main Results:

  • The study cohort comprised 670 children (112 immigrants, 558 adoptees).
  • Overall positive TST incidence was 12.2%, with significantly higher rates in immigrants (31%) compared to adoptees (8%).
  • Older age at arrival in Canada and prior BCG vaccination were identified as independent risk factors for positive TST.

Conclusions:

  • Latent tuberculosis infection is a frequent issue among foreign-born children in Canada.
  • The elevated TST positivity in immigrant children is likely linked to their older age upon arrival.
  • Targeted screening and risk factor identification are essential for managing TB in this vulnerable pediatric group.
Abstract

Related Concept Videos

Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis01:23

Tuberculosis

Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...